Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 8
Submit an article Journal homepage
122
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Hypergammaglobulinemia as a presenting feature of Mantle cell lymphoma

Li Liua Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4303-2152
ORCID Icon,
Diana G. Adlowitza Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA
,
Philip Rocka Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA
,
Carla Casulob Department of Hematology & Oncology, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
&
W. Richard Buracka Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USACorrespondence[email protected]
Pages 2005-2008 | Received 05 Sep 2021, Accepted 09 Mar 2022, Published online: 31 Mar 2022

References

  • Dispenzieri A, Gertz MA, Therneau TM, et al. Retrospective cohort study of 148 patients with polyclonal gammopathy. Mayo Clin Proc. 2001;76(5):476–487.
  • Amlot PL, Green L. Serum immunoglobulins G, A, M, D and E concentrations in lymphomas. Br J Cancer. 1979;40(3):371–379.
  • Miller DG. Patterns of immunological deficiency in lymphomas and leukemias. Ann Intern Med. 1962;57(5):703–716.
  • Tienhaara A, Irjala K, Rajamaki A, et al. Four monoclonal immunoglobulins in a patient with chronic lymphocytic leukemia. Clin Chem. 1986;32(4):703–705.
  • Qian GX, Fu SM, Solanki DL, et al. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM. J Immunol. 1984;133:3396–3400.
  • Braunstein AH, Keren DF. Monoclonal gammopathy (IgM-kappa) in a patient with Burkitt’s lymphoma. Case report and literature review. Arch Pathol Lab Med. 1983;107:235–238.
  • Lunning MA, Vose JM. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. Blood. 2017;129(9):1095–1102.
  • Xu-Monette ZY, Zhou J, Young KH. PD-1 expression and clinical PD-1 blockade in B-cell lymphomas. Blood. 2018;131(1):68–83.
  • Xerri L, Chetaille B, Serriari N, et al. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Hum Pathol. 2008;39(7):1050–1058.
  • Muenst S, Hoeller S, Willi N, et al. Diagnostic and prognostic utility of PD-1 in B cell lymphomas. Dis Markers. 2010;29(1):47–53.
  • Burack WR, Spence JM, Spence JP, et al. Patient-derived xenografts of low-grade B-cell lymphomas demonstrate roles of the tumor microenvironment. Blood Adv. 2017;1(16):1263–1273.
  • Armand P, Shipp MA, Ribrag V, et al. Programmed death-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure. J Clin Oncol. 2016;34(31):3733–3739.
  • Armand P, Engert A, Younes A, et al. Nivolumab for relapsed/refractory classic hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial. J Clin Oncol. 2018;36(14):1428–1439.
  • Ansell SM, Lesokhin AM, Borrello I, et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N Engl J Med. 2015;372(4):311–319.
  • Lesokhin AM, Ansell SM, Armand P, et al. Nivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a phase Ib study. J Clin Oncol. 2016;34(23):2698–2704.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.